0001615219-21-000095.txt : 20211105 0001615219-21-000095.hdr.sgml : 20211105 20211105145402 ACCESSION NUMBER: 0001615219-21-000095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211103 FILED AS OF DATE: 20211105 DATE AS OF CHANGE: 20211105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosenblum Mark J CENTRAL INDEX KEY: 0001329154 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36812 FILM NUMBER: 211384111 MAIL ADDRESS: STREET 1: 3990 SPRING VALLEY ROAD, APT. 1218 CITY: DALLAS STATE: TX ZIP: 75244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 346-772-0346 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BLVD STREET 2: SUITE J-608 CITY: HOUSTON STATE: TX ZIP: 77021 FORMER COMPANY: FORMER CONFORMED NAME: Flex Pharma, Inc. DATE OF NAME CHANGE: 20140730 4 1 wf-form4_163613842601112.xml FORM 4 X0306 4 2021-11-03 0 0001615219 Salarius Pharmaceuticals, Inc. SLRX 0001329154 Rosenblum Mark J C/O SALARIUS PHARMACEUTICALS, INC. 2450 HOLCOMBE BLVD., SUITE X HOUSTON TX 77021 0 1 0 0 Exec VP Finance, CFO Common Stock 2021-11-03 4 A 0 7787 0.718 A 34073 D The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan. /s/ Mark J. Rosenblum 2021-11-05